Your browser doesn't support javascript.
loading
CD16+NK-92 and anti-CD123 monoclonal antibody prolongs survival in primary human acute myeloid leukemia xenografted mice.
Williams, Brent A; Wang, Xing-Hua; Leyton, Jeffrey V; Maghera, Sonam; Deif, Bishoy; Reilly, Raymond M; Minden, Mark D; Keating, Armand.
Affiliation
  • Williams BA; Cell Therapy Program, Princess Margaret Cancer Centre, Toronto, Ontario, Canada brentw@uhnres.utoronto.ca brentwilliams.brent@gmail.com.
  • Wang XH; Institute of Medical Science, University of Toronto, Ontario, Canada.
  • Leyton JV; Cell Therapy Program, Princess Margaret Cancer Centre, Toronto, Ontario, Canada.
  • Maghera S; Department of Nuclear Medicine and Radiobiology, Université de Sherbrooke, Quebec, Canada.
  • Deif B; Cell Therapy Program, Princess Margaret Cancer Centre, Toronto, Ontario, Canada.
  • Reilly RM; Institute of Medical Science, University of Toronto, Ontario, Canada.
  • Minden MD; Cell Therapy Program, Princess Margaret Cancer Centre, Toronto, Ontario, Canada.
  • Keating A; Department of Medical Imaging, University of Toronto, Ontario, Canada.
Haematologica ; 103(10): 1720-1729, 2018 10.
Article in En | MEDLINE | ID: mdl-29976748
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Leukemia, Myeloid, Acute / Receptors, IgG / Interleukin-3 Receptor alpha Subunit / Antineoplastic Agents, Immunological / Neoplasm Proteins Limits: Animals / Humans Language: En Journal: Haematologica Year: 2018 Document type: Article
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Leukemia, Myeloid, Acute / Receptors, IgG / Interleukin-3 Receptor alpha Subunit / Antineoplastic Agents, Immunological / Neoplasm Proteins Limits: Animals / Humans Language: En Journal: Haematologica Year: 2018 Document type: Article